Developer docs
API playgroundTry for free, no card

Search company profiles

AMBROSIA VENTURES LLP

Full company profile

uuid028sh5w

Namestring
AMBROSIA VENTURES LLP
Legal namestring
Ambrosia Ventures LLP
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Ambrosia Ventures LLP is a boutique strategic consulting and M&A advisory firm focused on the life sciences sector. Founded in 2023 by Issa Kildani as Founder & Managing Partner, the firm serves biotech, pharmaceutical, and medtech companies alongside investors, private equity firms, and corporate leadership teams. Service lines are organized around three pillars: Strategic Consulting (market intelligence, corporate strategy, go-to-market, organizational transformation), M&A Advisory and Deal Execution (target identification, commercial/scientific due diligence, valuation, deal structuring, and post-merger integration), and Investor and Licensing Strategy (fundraising readiness, in/out-licensing, and regulatory compliance advisory). The firm claims a global operating footprint spanning the US, UK, India, China, Singapore, and Brazil.

The firm's technology layer centers on alaric, a proprietary Life Sciences M&A Analytics Tool launched in 2025 that provides benchmarking, market forecasting, and M&A intelligence. Adjacent capabilities include AI-driven data hubs for real-time market and customer analytics, and blockchain consulting for biotech supply chain traceability and clinical trial data integrity. The firm references predictive analytics, NLP-based contract analysis (using named third-party tools such as Kira and Seal), generative AI, and machine learning for applications ranging from market forecasting to genomic target identification and virtual screening. These AI capabilities are positioned as supplementary to human-led advisory delivery rather than as standalone products.

The business model is professional services-based: engagements are sold direct via the firm website and Calendly-scheduled strategy calls, with quote-based pricing that can be structured as flat fees, time and materials, or success-based arrangements. Go-to-market is sales-led, supported by content marketing through a blog, active social presence on LinkedIn, Facebook, and Instagram, and participation in industry conferences. The firm is privately held with no disclosed institutional investment, no parent company, and no reported revenue or headcount.

Short descriptiontext

Ambrosia Ventures LLP is a boutique life sciences consulting and M&A advisory firm serving biotech, pharma, medtech companies, and investors with strategic consulting, deal execution, and investor readiness services supported by its proprietary alaric analytics platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDetroit, United States
HQ citystring
Detroit
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
life sciences consulting, M&A advisory, biotech strategy, pharma consulting, investor readiness
Industry3 codes
PRIMARYFSAEAGAJ
Industry-Specialist / Sector-Focused M&A Advisory
SECONDARYBPAHAOAA
M&A Advisory (Buy-Side & Sell-Side)
SECONDARYBPAHACAM
Innovation, Product & R&D Consulting
NAICS code4 codes
  • Management Consulting Services54161
  • Securities, Commodity Contracts, and Other Financial Investments and Related Activities523
  • Miscellaneous Intermediation52391
  • Other Management Consulting Services541618
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Engineering, Accounting, Research, Management8700
Product category
Life Sciences Management Consulting
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Strategic Consulting Services
TypeProfessional Services
Description

Advisory engagements providing life sciences business consulting including market intelligence, corporate strategy, organizational transformation, and go-to-market strategies. Delivered as customized advisory projects tailored to each client's unique objectives.

ambrosiaventures.co
2M&A Advisory Services
TypeProfessional Services
Description

Deal execution support including target identification, due diligence, valuation, deal structuring, negotiation, and post-merger integration services for life sciences transactions.

ambrosiaventures.co
3Investor & Licensing Advisory
TypeProfessional Services
Description

Investor readiness, fundraising support, in-licensing and out-licensing facilitation, and regulatory compliance advisory for life sciences companies and investors.

ambrosiaventures.co
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Custom consulting engagements with quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Fees and deliverables outlined per engagement. Pricing can be flat, time & materials, or success-based. Out-of-pocket costs including analytics, modelling, implementation, travel, and software licensing are clarified upfront.

ambrosiaventures.co
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Ambrosia Ventures is a boutique consulting firm that delivers strategic consulting, M&A advisory, and investor/licensing advisory services to life sciences companies. Its core deliverables include market intelligence, corporate and go-to-market strategy, target identification, due diligence, deal structuring, post-merger integration, and fundraising support for biotech, pharma, and medtech clients. Engagements are delivered by senior advisors and underpinned by a proprietary Life Sciences M&A Analytics Tool (alaric) and AI-driven analytics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Proven track record measured by clients' continued growth and successful deal closures
Product overview1 text field

Ambrosia Ventures LLP is a boutique strategic consulting and M&A advisory firm specializing in the life sciences sector. The firm operates as a services-based consultancy rather than a software platform, offering strategic consulting, M&A advisory, and investor/ licensing strategy as its core service lines. The Life Sciences M&A Analytics Tool (alaric) serves as a proprietary analytics platform that underpins the firm's consulting engagements, providing benchmarking, forecasting, and intelligence capabilities. AI-driven data hubs and biotech blockchain solutions represent technology capabilities the firm employs to deliver insights on market performance, clinical trial optimization, and supply chain transparency. The core offering is human-led consulting supplemented by proprietary analytical tools and AI-enabled data processing.

Product and service4 records
1Strategic Consulting Services
CategoryCore Service
Description

Life sciences business consulting covering market intelligence and competitive positioning, corporate strategy and organizational transformation, and go-to-market and commercialization strategy for biotech, pharma, and medtech companies. Includes AI-driven operational excellence for R&D, clinical trials, and manufacturing optimization.

2M&A Advisory & Deal Execution
CategoryCore Service
Description

M&A advisory covering target identification and market mapping, commercial and scientific due diligence and valuation, deal structuring and negotiation, and post-merger integration strategy for life sciences transactions.

3Investor & Licensing Strategy
CategoryCore Service
Description

Investor readiness and fundraising support for IPOs and private equity funding, in-licensing and out-licensing facilitation for drug assets and IP, and regulatory risk and compliance advisory for life sciences companies and investors.

4Life Sciences M&A Analytics Tool (alaric)
CategoryPlatform / Analytics Tool
Description

Proprietary analytics platform providing high-precision benchmarking, market forecasting, M&A intelligence, and strategic insights for biotech and pharmaceutical clients across deal identification, valuation, and post-merger integration phases.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialized strategy consulting firm for life sciences companies and investors, providing commercial diligence, M&A advisory, and strategic assessments — a near-direct competitor to Ambrosia in size and life sciences M&A focus.

TypeDirect peer
Description

Boutique life sciences-focused advisory firm providing commercial diligence, strategic advisory, and financing support to biotech and pharma companies and investors — directly comparable in size, specialization, and M&A advisory positioning.

TypeBroad incumbent
Description

Global consulting firm with a substantial life sciences practice covering commercial strategy, pricing, and M&A support for pharma and biotech — competes with Ambrosia on strategy and licensing/commercialization engagements.

TypeBroad incumbent
Description

Global strategy consulting firm with one of the largest dedicated life sciences practices, providing strategy, M&A advisory, and commercial diligence to biotech and pharma — directly comparable in service mix but at vastly larger scale and brand recognition than Ambrosia Ventures.

5ZS Associates
TypeBroad incumbent
Description

Global consulting firm with a deep life sciences practice combining strategy consulting, M&A advisory, and analytics/AI capabilities for pharma and biotech — overlaps with Ambrosia's services and AI/analytics positioning but at materially larger scale.

TypeDirect peer
Description

Boutique life sciences strategy consulting firm focused on biotech, pharma, and medtech, offering commercial diligence, M&A support, and strategic advisory — a closest direct competitor to Ambrosia given similar size, vertical specialization, and service offering.

7Trinity Partners
TypeDirect peer
Description

Life sciences-focused strategy consulting firm offering commercial strategy, market research, and transaction advisory to biotech and pharma — a comparable boutique competitor with similar vertical focus and client base.

TypeBroad incumbent
Description

Global consulting firm with a Life Sciences practice providing M&A advisory, commercial diligence, and strategy consulting for biotech and pharma — overlaps broadly with Ambrosia's M&A and strategic consulting service lines.

TypeDirect peer
Description

Life sciences-focused strategy consulting firm serving biotech and pharma on commercial strategy, market access, and transaction support — directly comparable boutique competitor with similar vertical specialization and engagement types.

10Alvarez & Marsal Life Sciences
TypeBroad incumbent
Description

Global professional services firm with a dedicated Life Sciences practice providing transaction advisory, restructuring, and operational consulting to biotech and pharma — a comparable services competitor in life sciences M&A and turnaround advisory.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability11 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AMBROSIA VENTURES LLP

Life Sciences Management Consultingambrosiaventures.co

Ambrosia Ventures LLP is a boutique life sciences consulting and M&A advisory firm serving biotech, pharma, medtech companies, and investors with strategic consulting, deal execution, and investor readiness services supported by its proprietary alaric analytics platform.

What AMBROSIA VENTURES LLP does

Ambrosia Ventures LLP is a boutique strategic consulting and M&A advisory firm focused on the life sciences sector. Founded in 2023 by Issa Kildani as Founder & Managing Partner, the firm serves biotech, pharmaceutical, and medtech companies alongside investors, private equity firms, and corporate leadership teams. Service lines are organized around three pillars: Strategic Consulting (market intelligence, corporate strategy, go-to-market, organizational transformation), M&A Advisory and Deal Execution (target identification, commercial/scientific due diligence, valuation, deal structuring, and post-merger integration), and Investor and Licensing Strategy (fundraising readiness, in/out-licensing, and regulatory compliance advisory). The firm claims a global operating footprint spanning the US, UK, India, China, Singapore, and Brazil.

The firm's technology layer centers on alaric, a proprietary Life Sciences M&A Analytics Tool launched in 2025 that provides benchmarking, market forecasting, and M&A intelligence. Adjacent capabilities include AI-driven data hubs for real-time market and customer analytics, and blockchain consulting for biotech supply chain traceability and clinical trial data integrity. The firm references predictive analytics, NLP-based contract analysis (using named third-party tools such as Kira and Seal), generative AI, and machine learning for applications ranging from market forecasting to genomic target identification and virtual screening. These AI capabilities are positioned as supplementary to human-led advisory delivery rather than as standalone products.

The business model is professional services-based: engagements are sold direct via the firm website and Calendly-scheduled strategy calls, with quote-based pricing that can be structured as flat fees, time and materials, or success-based arrangements. Go-to-market is sales-led, supported by content marketing through a blog, active social presence on LinkedIn, Facebook, and Instagram, and participation in industry conferences. The firm is privately held with no disclosed institutional investment, no parent company, and no reported revenue or headcount.

AMBROSIA VENTURES LLP firmographics

Firmographics
Name
AMBROSIA VENTURES LLP
Legal name
Ambrosia Ventures LLP
Website
https://ambrosiaventures.co
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Short description
Ambrosia Ventures LLP is a boutique life sciences consulting and M&A advisory firm serving biotech, pharma, medtech companies, and investors with strategic consulting, deal execution, and investor readiness services supported by its proprietary alaric analytics platform.
Ownership category
akta.pro rank

AMBROSIA VENTURES LLP industry classification

Industry
Product category
Life Sciences Management Consulting
NAICS
Management Consulting Services (54161), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Miscellaneous Intermediation (52391), Other Management Consulting Services (541618)
SIC
Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)
akta.pro industry
PRIMARYFSAEAGAJ
Industry-Specialist / Sector-Focused M&A Advisory
SECONDARYBPAHAOAA
M&A Advisory (Buy-Side & Sell-Side)
SECONDARYBPAHACAM
Innovation, Product & R&D Consulting

Keywords

  • Life sciences consulting
  • M&A advisory
  • Biotech strategy
  • Pharma consulting
  • Investor readiness

Where AMBROSIA VENTURES LLP is headquartered

Location

Headquarters

HQ city
Detroit
HQ country
United States
HQ region
North America

Markets served

AMBROSIA VENTURES LLP business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Strategic Consulting Services: Advisory engagements providing life sciences business consulting including market intelligence, corporate strategy, organizational transformation, and go-to-market strategies. Delivered as customized advisory projects tailored to each client's unique objectives.
  2. M&A Advisory Services: Deal execution support including target identification, due diligence, valuation, deal structuring, negotiation, and post-merger integration services for life sciences transactions.
  3. Investor & Licensing Advisory: Investor readiness, fundraising support, in-licensing and out-licensing facilitation, and regulatory compliance advisory for life sciences companies and investors.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom consulting engagements with quote-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

AMBROSIA VENTURES LLP product offering

Product offering

Core offering

Ambrosia Ventures is a boutique consulting firm that delivers strategic consulting, M&A advisory, and investor/licensing advisory services to life sciences companies. Its core deliverables include market intelligence, corporate and go-to-market strategy, target identification, due diligence, deal structuring, post-merger integration, and fundraising support for biotech, pharma, and medtech clients. Engagements are delivered by senior advisors and underpinned by a proprietary Life Sciences M&A Analytics Tool (alaric) and AI-driven analytics.

Product overview

Ambrosia Ventures LLP is a boutique strategic consulting and M&A advisory firm specializing in the life sciences sector. The firm operates as a services-based consultancy rather than a software platform, offering strategic consulting, M&A advisory, and investor/ licensing strategy as its core service lines. The Life Sciences M&A Analytics Tool (alaric) serves as a proprietary analytics platform that underpins the firm's consulting engagements, providing benchmarking, forecasting, and intelligence capabilities. AI-driven data hubs and biotech blockchain solutions represent technology capabilities the firm employs to deliver insights on market performance, clinical trial optimization, and supply chain transparency. The core offering is human-led consulting supplemented by proprietary analytical tools and AI-enabled data processing.

Differentiator

Problem solved

Functional benefit

Products and services

  • Strategic Consulting Services Life sciences business consulting covering market intelligence and competitive positioning, corporate strategy and organizational transformation, and go-to-market and commercialization strategy for biotech, pharma, and medtech companies. Includes AI-driven operational excellence for R&D, clinical trials, and manufacturing optimization.
  • M&A Advisory & Deal Execution M&A advisory covering target identification and market mapping, commercial and scientific due diligence and valuation, deal structuring and negotiation, and post-merger integration strategy for life sciences transactions.
  • Investor & Licensing Strategy Investor readiness and fundraising support for IPOs and private equity funding, in-licensing and out-licensing facilitation for drug assets and IP, and regulatory risk and compliance advisory for life sciences companies and investors.
  • Life Sciences M&A Analytics Tool (alaric) Proprietary analytics platform providing high-precision benchmarking, market forecasting, M&A intelligence, and strategic insights for biotech and pharmaceutical clients across deal identification, valuation, and post-merger integration phases.

Quantifiable outcome

  • Proven track record measured by clients' continued growth and successful deal closures

Companies that use AMBROSIA VENTURES LLP

Customer profile

Segments4 records

Ideal customer profiles4 records

AMBROSIA VENTURES LLP technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature3 records

AMBROSIA VENTURES LLP partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves1 record

Expansion highlights4 records

AMBROSIA VENTURES LLP competitors and assessment

Company assessment

Direct peers

  • Health Advances: Specialized strategy consulting firm for life sciences companies and investors, providing commercial diligence, M&A advisory, and strategic assessments — a near-direct competitor to Ambrosia in size and life sciences M&A focus.
  • Back Bay Life Science Advisors: Boutique life sciences-focused advisory firm providing commercial diligence, strategic advisory, and financing support to biotech and pharma companies and investors — directly comparable in size, specialization, and M&A advisory positioning.
  • ClearView Healthcare Partners: Boutique life sciences strategy consulting firm focused on biotech, pharma, and medtech, offering commercial diligence, M&A support, and strategic advisory — a closest direct competitor to Ambrosia given similar size, vertical specialization, and service offering.
  • Trinity Partners: Life sciences-focused strategy consulting firm offering commercial strategy, market research, and transaction advisory to biotech and pharma — a comparable boutique competitor with similar vertical focus and client base.
  • Putnam Associates: Life sciences-focused strategy consulting firm serving biotech and pharma on commercial strategy, market access, and transaction support — directly comparable boutique competitor with similar vertical specialization and engagement types.

Broad incumbents

  • Simon-Kucher & Partners: Global consulting firm with a substantial life sciences practice covering commercial strategy, pricing, and M&A support for pharma and biotech — competes with Ambrosia on strategy and licensing/commercialization engagements.
  • L.E.K. Consulting: Global strategy consulting firm with one of the largest dedicated life sciences practices, providing strategy, M&A advisory, and commercial diligence to biotech and pharma — directly comparable in service mix but at vastly larger scale and brand recognition than Ambrosia Ventures.
  • ZS Associates: Global consulting firm with a deep life sciences practice combining strategy consulting, M&A advisory, and analytics/AI capabilities for pharma and biotech — overlaps with Ambrosia's services and AI/analytics positioning but at materially larger scale.
  • Charles River Associates: Global consulting firm with a Life Sciences practice providing M&A advisory, commercial diligence, and strategy consulting for biotech and pharma — overlaps broadly with Ambrosia's M&A and strategic consulting service lines.
  • Alvarez & Marsal Life Sciences: Global professional services firm with a dedicated Life Sciences practice providing transaction advisory, restructuring, and operational consulting to biotech and pharma — a comparable services competitor in life sciences M&A and turnaround advisory.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

AMBROSIA VENTURES LLP social profiles

Digital presence

AMBROSIA VENTURES LLP financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AMBROSIA VENTURES LLP leadership team

Management profile

Number of profiles

Profiles1 record

AMBROSIA VENTURES LLP funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AMBROSIA VENTURES LLP M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AMBROSIA VENTURES LLP

What does AMBROSIA VENTURES LLP do?

Ambrosia Ventures is a boutique consulting firm that delivers strategic consulting, M&A advisory, and investor/licensing advisory services to life sciences companies. Its core deliverables include market intelligence, corporate and go-to-market strategy, target identification, due diligence, deal structuring, post-merger integration, and fundraising support for biotech, pharma, and medtech clients. Engagements are delivered by senior advisors and underpinned by a proprietary Life Sciences M&A Analytics Tool (alaric) and AI-driven analytics.

Is AMBROSIA VENTURES LLP a public or private company?

AMBROSIA VENTURES LLP is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AMBROSIA VENTURES LLP founded?

AMBROSIA VENTURES LLP was founded in 2023. It employs 1 to 10 people.

Where is AMBROSIA VENTURES LLP based?

AMBROSIA VENTURES LLP is headquartered in Detroit, United States, in the North America region.

How does AMBROSIA VENTURES LLP make money?

Three revenue lines are on record. Strategic Consulting Services are the primary driver. The others are M&A Advisory Services and investor & Licensing Advisory.

Who are AMBROSIA VENTURES LLP's main competitors?

Direct peers on record are Health Advances, Back Bay Life Science Advisors, ClearView Healthcare Partners, Trinity Partners and Putnam Associates. Broad incumbents are Simon-Kucher & Partners, L.E.K. Consulting, ZS Associates, Charles River Associates and Alvarez & Marsal Life Sciences.

Does AMBROSIA VENTURES LLP have an API?

No public API is recorded for AMBROSIA VENTURES LLP.

What industry is AMBROSIA VENTURES LLP in?

AMBROSIA VENTURES LLP's product category is Life Sciences Management Consulting. Its primary akta.pro industry code is FSAEAGAJ, Industry-Specialist / Sector-Focused M&A Advisory, with a secondary code of BPAHAOAA, M&A Advisory (Buy-Side & Sell-Side). Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales